Evidence map›Paper›PMID 27618553›Full record

ArticleNature immunology2016

Evidence of innate lymphoid cell redundancy in humans.

Frédéric Vély, Vincent Barlogis, Blandine Vallentin, Bénédicte Neven, Christelle Piperoglou, Mikael Ebbo, Thibaut Perchet, Maxime Petit, Nadia Yessaad, Fabien Touzot and 15 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 184 papers.

0numbers the graph read from it
0cells of the map it votes in
184citing papers in PubMed
22.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

184 citing papers in PubMed, 304 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Lymphedema in patients with X-linked severe combined immunodeficiency.The journal of allergy and clinical immunology. Global · 2026
    Article
  7. Review
  8. Innate Lymphoid Cells Are the Rheostat of Immune Response in the Kidney.Journal of cellular and molecular medicine · 2025
    Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Group 3 innate lymphoid cells in intestinal health and disease.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  19. Article
  20. Review

124 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 11 institutions in 3 countries.

Frédéric VélyAix Marseille Université, CNRS, INSERM, CIML, Marseille, France.
Vincent BarlogisAPHM, Hôpital de la Timone, Service d'Hématologie et Oncologie Pédiatrique, Marseille, France.
Blandine VallentinAPHM, Hôpital de la Timone, Service d'Hématologie et Oncologie Pédiatrique, Marseille, France.
Bénédicte NevenAPHP, Hôpital Universitaire Necker-Enfants Malades, Centre de Référence Déficits Immunitaires Héréditaires, Paris, France.
Christelle PiperoglouAix Marseille Université, CNRS, INSERM, CIML, Marseille, France.
Mikael EbboAix Marseille Université, CNRS, INSERM, CIML, Marseille, France.
Thibaut PerchetInstitut Pasteur, Unité de Lymphopoièse, INSERM, Paris, France.
Maxime PetitInstitut Pasteur, Unité de Lymphopoièse, INSERM, Paris, France.
Nadia YessaadMI-mAbs consortium, Aix-Marseille University, Marseille, France.
Fabien TouzotUniversité Paris Descartes-Sorbonne Paris Cité, Institut Imagine, Paris, France.
Julie BruneauUniversité Paris Descartes-Sorbonne Paris Cité, Institut Imagine, Paris, France.
Nizar MahlaouiAPHP, Hôpital Universitaire Necker-Enfants Malades, Centre de Référence Déficits Immunitaires Héréditaires, Paris, France.
Nicolas ZucchiniBD Biosciences, Le Pont-de-Claix, France.
Catherine FarnarierAPHM, Hôpital de la Conception, Service d'Immunologie, Marseille, France.
Gérard MichelAPHM, Hôpital de la Timone, Service d'Hématologie et Oncologie Pédiatrique, Marseille, France.
Despina MoshousAPHP, Hôpital Universitaire Necker-Enfants Malades, Centre de Référence Déficits Immunitaires Héréditaires, Paris, France.
Stéphane BlancheAPHP, Hôpital Universitaire Necker-Enfants Malades, Centre de Référence Déficits Immunitaires Héréditaires, Paris, France.
Arnaud DujardinInnate-Pharma, Marseille, France.
Hergen SpitsAcademic Medical Center at the University of Amsterdam, Arizona Amsterdam, the Netherlands.
Jörg H W DistlerDepartment of Internal Medicine, Rheumatology &Immunology, University of Erlangen-Nuremberg, Erlangen, Germany.
Andreas RammingDepartment of Internal Medicine, Rheumatology &Immunology, University of Erlangen-Nuremberg, Erlangen, Germany.
Capucine PicardAPHP, Hôpital Universitaire Necker-Enfants Malades, Centre de Référence Déficits Immunitaires Héréditaires, Paris, France.ORCID http://orcid.org/0000-0001-8788-5056
Rachel GolubInstitut Pasteur, Unité de Lymphopoièse, INSERM, Paris, France.
Alain FischerAPHP, Hôpital Universitaire Necker-Enfants Malades, Centre de Référence Déficits Immunitaires Héréditaires, Paris, France.
Eric VivierAix Marseille Université, CNRS, INSERM, CIML, Marseille, France.
Délégation Paris 5 · FRCentre National de la Recherche Scientifique · FRInserm · FRFriedrich-Alexander-Universität Erlangen-Nürnberg · DEHôpital de la Timone · FRAix-Marseille Université · FRAmsterdam UMC Location University of Amsterdam · NLBecton Dickinson (France) · FRCentre de Référence Déficits Immunitaires Héréditaires · FRHôpital de la Conception · FRInnate Pharma (France) · FR

Funding

European Research Council 268537
6 · The paper itself

Abstract

Innate lymphoid cells (ILCs) have potent immunological functions in experimental conditions in mice, but their contributions to immunity in natural conditions in humans have remained unclear. We investigated the presence of ILCs in a cohort of patients with severe combined immunodeficiency (SCID). All ILC subsets were absent in patients with SCID who had mutation of the gene encoding the common γ-chain cytokine receptor subunit IL-2Rγ or the gene encoding the tyrosine kinase JAK3. T cell reconstitution was observed in patients with SCID after hematopoietic stem cell transplantation (HSCT), but the patients still had considerably fewer ILCs in the absence of myeloablation than did healthy control subjects, with the exception of rare cases of reconstitution of the ILC1 subset of ILCs. Notably, the ILC deficiencies observed were not associated with any particular susceptibility to disease, with follow-up extending from 7 years to 39 years after HSCT. We thus report here selective ILC deficiency in humans and show that ILCs might be dispensable in natural conditions, if T cells are present and B cell function is preserved.

Indexed as

Immunity, InnateAdolescentAdultAnimalsBiomarkersChildDisease Models, AnimalGraft SurvivalHematopoietic Stem Cell TransplantationHumansImmune SystemInterleukin Receptor Common gamma SubunitIntestinal MucosaJanus Kinase 3Lymphocyte CountLymphocytesBiomarkersInterleukin Receptor Common gamma SubunitJanus Kinase 3

Identifiers

PMID27618553
PMCPMC5074366
OpenAlexW2519136071

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.